Home
Conditions
Leukemia, Biphenotypic, Acute

Clinical trial condition

Leukemia, Biphenotypic, Acute

Explore clinical trials studying Leukemia, Biphenotypic, Acute. Study availability and eligibility vary by location and protocol.

198 public trials 48 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Biphenotypic, Acute trial results

Not Yet Recruiting

Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT

NCT07254793

Conditions: Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Acute Undifferentiated Leukemia (AUL), +31 more
Locations: The University of Arizona Cancer Center Tucson, Arizona, United States

View Trial Details

Not Yet Recruiting

Real World Asparaginase Therapy Toxicity

NCT07008027

Conditions: Chemically-Induced Disorders, Drug Toxicity, Drug-Related Side Effects and Adverse Reactions, +12 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Not Yet Recruiting

Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute Lymphoblastic Leukemia With a Genetic Change Requiring More Treatment

NCT07636564

Conditions: Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, +24 more
Locations: Not specified

View Trial Details

Completed

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD

NCT02220985

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage, +57 more
Locations: University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States

Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies

NCT04191187

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Biphenotypic Acute Leukemia, +56 more
Locations: H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States

View Trial Details

Completed

Study of Escalating Doses of INA03 Administered Intravenously as Single Agent in Adult Patients With Relapse/Refractory Acute Leukemia

NCT03957915

Conditions: Acute Lymphoblastic Leukemia Recurrent, Acute Lymphoblastic Leukemia, in Relapse, Acute Myeloid Leukaemia Recurrent, +16 more
Locations: Institut Paoli-Calmettes Marseille, Bouches-du Rhône, France

Chu Bordeaux Hopital Haut Leveque Pessac, France

IUCT Toulouse, France

View Trial Details

Completed

HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide

NCT02793544

Conditions: Acute Biphenotypic Leukemia (ABL), Acute Lymphoblastic Leukemia (ALL)/T Lymphoblastic Lymphoma, Acute Myelogenous Leukemia (AML), +26 more
Locations: Shands HealthCare & University of Florida Gainesville, Florida, United States

University of Miami Miami, Florida, United States

H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States

View Trial Details

Completed

Blinatumomab for Treatment of R/R or MRD-positive CD19-Positive MPAL

NCT04827745

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations: Greenebaum Cancer Center at University of Maryland Medical Center Baltimore, Maryland, United States

View Trial Details

Completed

Nivolumab and Azacitidine With or Without Ipilimumab in Treating Patients With Refractory/Relapsed or Newly Diagnosed Acute Myeloid Leukemia

NCT02397720

Conditions: Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, +27 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease

NCT00719888

Conditions: Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +65 more
Locations: University of Colorado Hospital Aurora, Colorado, United States

VA Puget Sound Health Care System Seattle, Washington, United States

Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Leukemia, Biphenotypic, Acute

Leukemia, Biphenotypic, Acute trial results

Related conditions